2. Официальная статистика коронавируса. https://gogov.ru/articles/covid-19.

3. Ющук Н.Д., Мартынов Ю.В. Эпидемический процесс. В кн. Эпидемиология: Учеб. пособие. 2-е изд., перераб. и доп. М.: Медицина; 2003: 21, 23–24.

Yushchuk N.D., Martynov Y.V.

4. Гундаров И.А., Гундаров Б.И. Загадки волн респираторных вирусных инфекций. https://ibzh.ru/zagadki-voln-respiratornyh-virusnyh-infekciy-t1766/#p4272

Gundarov I.A., Gundarov B.I.

5. Борисевич С. В., Сизикова Т.Е., Лебедев В. Н. Пандемия COVID-19: Анализ возможных сценариев развития эпидемии заболевания в России. Вестник войск РХБ защиты 2020; (1): 116–30. DOI:10.35825/2587-5728-2020-4-2-116-130

Borisevich S.V., Sizikova T.E., Lebedev V.N.

6. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 2020; 382(13): 1199–207. DOI: 10.1056/NEJMoa2001316

7. Riou J., Althaus C.L. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020; 25(4): 2000058. DOI: 10.2807/1560-7917.ES.2020.25.4.2000058

8. Wu J.T., Leung K., Bushman M., Kishore N., Niehus R., de Salazar P.M. et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat. Med. 2020; 26(4): 506–10. DOI: 10.1038/s41591-020-0822-7

9. Singanayagam A., Hakki S., Dunning J., Madon K.J., Crone М.А., Koycheva А. et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis. 2022; 22(2): 183–95. DOI: 10.1016/S1473-3099(21)00648-4.

10. Sanche S., Lin Y.T., Xu C., Romero-Severson Е., Hengartner N., Ke R. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg. Infect. Dis. 2020; 26(7): 1470–7. DOI: 10.3201/eid2607.200282.

11. Акимкин В.Г., Попова А.Ю., Хафизов К.Ф., Дубоделов Д.В., Углева С.В., Семененко Т.А. и др. COVID-19: эволюция пандемии в России. Сообщение II: динамика циркуляции геновариантов вируса SARS-CoV-2. Журнал микробиологии, эпидемиологии и иммунобиологии 2022; 99(4): 381–96. DOI: 10.36233/ 0372-9311-295

Akimkin V.G., Popova A.Y., Hafizov K.F., Dubodelov D.V., Ugleva S.V., Semenenko T.A. et al.

12. Tracking SARS-CoV-2 variants. www.who.int

13. Covid infections rising again across UK–ONS. BBC News. 11 March 2022. https://en.org/wiki/COVID-19_pandemic_in_the_United_Kingdom

14. ECDC. Changes to list of SARS-CoV-2 variants of concern, variants of interest, and variants under monitoring. (12 May 2022). https://www.ecdc.europa.eu/sites/default/files/documents/Variants%20page%20changelog.pdf

15. SARS-CoV-2 Variant Classifications and Definitions. CDC.gov. Centers for Disease Control and Prevention. 11 February 2020. Archived from the original on 29 June 2021.

16. Russell P. Omicron XBB.1.5: What Do We Know So Far? https://www.medcape.co.uk

17. Статистика вакцинации от коронавируса в России и в мире https://gogov.ru/articles/covid-v-stats

[Statistics of vaccination against coronavirus in Russia and in the World]. (In Russ.). https://gogov.ru/articles/covid-v-stats

18. Ferguson N., Ghani A., Cori A., Hogan A., Hinsley W., Volz E. Growth, population distribution and immune escape of the Omicron in England (Technical report). WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis. Imperial College London. DOI: 10.25561/93038.

19. Goldberg Y., Mande M.l., Bar-On Y.M., Bodenheimer O., Freedman L., Ash N., et al. Protection and waning of natural and hybrid COVID-19 immunity BMJ YALE 2021, December,4 DOI: 10.1101/2021.12.04.21267114

20. Gazit S., Shlezinger R., Perez G., Lotan R., Peretz A., Ben-Tov A. et al. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. medRxiv preprint DOI: 10.1101/2021.08.24.21262415; this version posted August 25, 2021

21. Акимкин В.Г., Давидова Н.Г., Углева С.В., Понежева Ж.Б., Шабалина С.В. Формирование очагов COVID-19 в закрытых коллективах. Эпидемиол. инфекц. болезни. Актуал. вопр. 2022; 12(2): 52–9. DOI: 10.18565/epidem.2022.12.2.55-9

Akimkin V.G., Davidova N.G., Ugleva S.V., Ponegeva G.B., Shabalina S.V.

22. Cele S., Jackson L., Khoury D.S., Khan K., Moyo-Gwete T., Tegally H. et al. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv